comparemela.com

Latest Breaking News On - Plexium president - Page 1 : comparemela.com

PLEXIUM ANNOUNCES APPOINTMENT OF SUZANNE ZOUMARAS AS EXECUTIVE VICE PRESIDENT, HEAD OF HUMAN RESOURCES

/PRNewswire/ Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of Suzanne.

United statesSan diegoSan diego state universityJuniper pointAmy conradPercival barretto koUniversity of californiaArena pharmaceuticalsGlobal human resources at atmel corporationPrnewswire plexium incSuzanne zoumarasExecutive vice presidentPlexium presidentTargeted protein degradationManaging partnerHuman capital resource partners

PLEXIUM STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENT OF DANIEL SIPES AS SENIOR VICE PRESIDENT, HEAD OF TECHNOLOGY

/PRNewswire/ Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of Daniel Sipes.

United statesJuniper pointAmy conradPercival barretto koUniversity of californiaKalypsys incLigand pharmaceuticalsGenomics institute of the novartis research foundationHead of technologyCalifornia state universityPrnewswire plexium incDaniel sipesSenior vice presidentPlexium presidentTargeted protein degradationSite head san diego

PLEXIUM APPOINTS BRIAN WONG, M D , PH D , TO ITS BOARD OF DIRECTORS

/PRNewswire/ Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of Brian Wong as.

Amy conradPercival barretto koBrian wongRockefeller universityRigel pharmaceuticalsWeill cornell medical collegePrnewswire plexium incPlexium presidentTargeted protein degradationSenior vice presidentFive prime therapeuticsInflammation disease biology areaMedia contact

Plexium Appoints Stephen Mullennix as Chief Financial Officer

/PRNewswire/ Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of Stephen.

Amy conradPercival barretto koUs renewables groupDartmouth collegeUrogen pharma ltdOperations at solarreserveProsciento incPrnewswire plexium incStephen mullennixChief financial officerPlexium presidentTargeted protein degradationChief operating officerUrogen pharmaSenior vice presidentManaging director

Abbvie and Plexium Enter Into Multi-Target Strategic Collaboration To Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions

/PRNewswire/ Plexium, Inc. (Plexium) and AbbVie (NYSE: ABBV) have entered into an exclusive strategic collaboration to develop and commercialize novel.

Eric karranAmy conradPercival barretto koPlexium incExchange commissionTargeted protein degradationPlexium presidentVice presidentNeuroscience discoveryAllergan aestheticsPrivate securities litigation reform actQuarterly reportsMedia contact

vimarsana © 2020. All Rights Reserved.